Read the full press release >> ROSEMONT, Ill. (Oct. 30, 2024) — A new initiative by the American Academy of Dermatology aims to shed light on an often misunderstood and debilitating condition, hidradenitis suppurativa (HS). HS is a chronic progressive condition that can cause painful and boil-like bumps, particularly in a patient’s armpits, thighs, and groin.[…]
Pharmaceutical Executive October 25, 2024 Read the full article >> Despite a recent FDA Complete Response Letter issued to Lykos for midomafetamine capsules for the treatment of post-traumatic stress disorder, experts believe that the future is bright for psychedelic drugs that treat mental health conditions. On August 9, 2024, the FDA announced that it had[…]
Authority Magazine October 6, 2024 Read the full article >> Invest in training and upskilling — Ensuring teams are equipped with the necessary skillset to work alongside AI is critical for success and responsible use of the technology. This includes comprehensive training on the foundation of AI, implementing AI, and special use cases of AI in[…]
Market Access Today October 5, 2024 Read the full article >> Key Questions Answered What are the primary areas of specialization for an insights-driven technology and data company? How does such a company (an insights-driven technology and data company) utilize AI in its operations? In what ways does this impact patient outcomes and research advancement?[…]
Healio October 2, 2024 Read the full article >> The future of Alzheimer’s disease detection and treatment may lie in AI-based datasets encompassing an abundance of real-world evidence from a large number of patients, an expert said. Healio spoke to Carl D. Marci, MD, chief clinical officer at Boston-based OM1, to gain his insights into how his[…]
